cd81 tetraspanin
Recently Published Documents


TOTAL DOCUMENTS

8
(FIVE YEARS 0)

H-INDEX

7
(FIVE YEARS 0)

IUBMB Life ◽  
2018 ◽  
Vol 70 (11) ◽  
pp. 1144-1155 ◽  
Author(s):  
Evgeniya E. Burkova ◽  
Pavel S. Dmitrenok ◽  
Dmitrii V. Bulgakov ◽  
Valentin V. Vlassov ◽  
Elena I. Ryabchikova ◽  
...  

2014 ◽  
Vol 107 (1) ◽  
pp. 100-113 ◽  
Author(s):  
Yahya Homsi ◽  
Jan-Gero Schloetel ◽  
Konstanze D. Scheffer ◽  
Thomas H. Schmidt ◽  
Nicolas Destainville ◽  
...  
Keyword(s):  

2011 ◽  
Vol 108 (11) ◽  
pp. 2623-2633 ◽  
Author(s):  
A.F. Rodrigues ◽  
M.R. Guerreiro ◽  
V.M. Santiago ◽  
C. Dalba ◽  
D. Klatzmann ◽  
...  

2008 ◽  
Vol 82 (7) ◽  
pp. 3555-3560 ◽  
Author(s):  
Laurent Meertens ◽  
Claire Bertaux ◽  
Lisa Cukierman ◽  
Emmanuel Cormier ◽  
Dimitri Lavillette ◽  
...  

ABSTRACT Hepatitis C virus (HCV) is a major cause of liver disease in humans. The CD81 tetraspanin is necessary but not sufficient for HCV penetration into hepatocytes, and it was recently reported that the tight junction protein claudin-1 is a critical HCV entry cofactor. Here, we confirm the role of claudin-1 in HCV entry. In addition, we show that claudin-6 and claudin-9 expressed in CD81+ cells also enable the entry of HCV pseudoparticles derived from six of the major genotypes. Whereas claudin-1, -6, and -9 function equally well as entry cofactors in endothelial cells, claudin-1 is more efficient in hepatoma cells. This suggests that additional cellular factors modulate the ability of claudins to function as HCV entry cofactors. Our work has generated novel and essential means to investigate the mechanism of HCV penetration into hepatocytes and the role of the claudin protein family in HCV dissemination, replication, and pathogenesis.


2003 ◽  
Vol 278 (43) ◽  
pp. 41624-41630 ◽  
Author(s):  
Birke Bartosch ◽  
Alessandra Vitelli ◽  
Christelle Granier ◽  
Caroline Goujon ◽  
Jean Dubuisson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document